Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma and Malignant Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227
What this trial is testing

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 33
Not applicableUnknownNCT02885623
What this trial is testing

Role of CX3CR1-expressing Cells in Hematologic Malignancy

Who this might be right for
CX3CR1 ProteinDiffuse Large B Cell LymphomaMultiple Myeloma
Saint Vincent's Hospital, Korea 50
Early research (Phase 1)Study completedNCT00990717
What this trial is testing

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
University Health Network, Toronto 8
Not applicableStudy completedNCT00333190
What this trial is testing

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyAMLALL+4 more
Dana-Farber Cancer Institute 30
Early research (Phase 1)Active Not RecruitingNCT00881920
What this trial is testing

Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL

Who this might be right for
LymphomaMyelomaLeukemia
Baylor College of Medicine 54
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Testing effectiveness (Phase 2)Ended earlyNCT01343368
What this trial is testing

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more
Masonic Cancer Center, University of Minnesota 19
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Early research (Phase 1)Ended earlyNCT00943293
What this trial is testing

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Who this might be right for
PreleukemiaMyeloproliferative DisordersLymphoma+2 more
University of Chicago 1
Early research (Phase 1)Study completedNCT00070616
What this trial is testing

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Who this might be right for
LeukemiaLymphomaMyeloma
Swedish Orphan Biovitrum 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05346809
What this trial is testing

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Who this might be right for
LymphomaMultiple MyelomaNon-Hodgkin Lymphoma+1 more
Divaya Bhutani 8
Testing effectiveness (Phase 2)Study completedNCT00241358
What this trial is testing

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more
Washington University School of Medicine 92
Testing effectiveness (Phase 2)Study completedNCT03317899
What this trial is testing

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaPlasma Cell Myeloma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 77
Early research (Phase 1)Study completedNCT00054236
What this trial is testing

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 55
Not applicableStudy completedNCT05053100
What this trial is testing

Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study

Who this might be right for
Acute LeukemiaDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+5 more
Mayo Clinic 100
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)Looking for participantsNCT04077307
What this trial is testing

A Study in Leukemia Patients With Karonudib

Who this might be right for
Leukemia
Thomas Helleday Foundation 50
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Not applicableLooking for participantsNCT06784167
What this trial is testing

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Who this might be right for
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more
OHSU Knight Cancer Institute 45
Next Page